Maxcyte (MXCT) Shares Outstanding (Weighted Average) (2019 - 2026)

Maxcyte (MXCT) has 8 years of Shares Outstanding (Weighted Average) data on file, last reported at $106.9 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 0.87% year-over-year to $106.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $106.9 million (up 0.87% YoY) and the FY2025 annual result came in at $106.4 million, up 1.51% from the prior year.
• Shares Outstanding (Weighted Average) held at $106.9 million in Q1 2026 per MXCT's latest filing, from $106.4 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $106.9 million in Q1 2026 and bottomed at $101.3 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $104.1 million (2024), against an average of $104.1 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) gained 22.55%; it then increased 0.87% in 2026.
• Tracing MXCT's Shares Outstanding (Weighted Average) over 5 years: stood at $101.7 million in 2022, then climbed by 1.54% to $103.3 million in 2023, then advanced by 1.53% to $104.8 million in 2024, then grew by 1.51% to $106.4 million in 2025, then grew by 0.42% to $106.9 million in 2026.
• Per Business Quant, the three latest MXCT Shares Outstanding (Weighted Average) figures stand at $106.9 million (Q1 2026), $106.4 million (Q4 2025), and $106.6 million (Q3 2025).

Peer Comparison